Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant
Recruitment status was: Active, not recruiting
RATIONALE: Questionnaires that measure coping may improve the ability to plan supportive care for patients undergoing donor bone marrow transplant.
PURPOSE: This clinical trial is studying coping in patients who are undergoing a donor bone marrow transplant.
|Chronic Myeloproliferative Disorders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic-Myeloproliferative Diseases Psychosocial Effects of Cancer and Its Treatment||Procedure: psychosocial assessment and care|
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Adjustment to Illness by Survival Rates in Allogeneic Bone Marrow Transplant (BMT): The Relative Importance of Lay Care-Partner Support|
- Compare modes of illness adjustment, presence or absence of an inpatient lay care-partner, and survival rates [ Time Frame: Through 100 days post transplant ]
|Study Start Date:||February 2006|
|Primary Completion Date:||December 2008 (Final data collection date for primary outcome measure)|
Procedure: psychosocial assessment and care
- Investigate the relative importance of having a consistent inpatient lay care-partner for patients undergoing allogeneic bone marrow transplantation, in terms of the effects on modes of adjustment to illness and survival.
OUTLINE: Patients undergo a 40-minute recorded oral interview in person to provide personal and social demographic data using a 20-item questionnaire (The Adjustment to Illness Questionnaire-Bone Marrow Transplantation) at baseline (pre-transplant) and at day 100 post-transplant.
PROJECTED ACCRUAL: A total of 40 patients will be accrued for this study.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00281814
|United States, Ohio|
|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|
|Cleveland, Ohio, United States, 44195|
|Study Chair:||Brian J. Bolwell, MD||Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|